RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
          
          https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
        Thromb Haemost 1997; 77(03): 605-606
DOI: 10.1055/s-0038-1656016
   DOI: 10.1055/s-0038-1656016
Letter to the Editor
   An Alternative Method for PAI-1 Promoter Polymorphism (4G/5G) Typing
Autoren
Weitere Informationen
            
               
                  
            
         
      
   Publikationsverlauf
Received 20. September 1996
Accepted after revision 14. November 1996
Publikationsdatum:
11. Juli 2018 (online)
- 
            
References
 - 1 Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993; 342: 1076-1079
 - 2 Ridker PM, Hennekens CH, Stampfer MJ, Manson J, Vaughan DE. Prospective study of endogenous tissue plasminogen activator and risk of stroke. Lancet 1994; 343: 0940-0943
 - 3 Chandler WL, Trimble SL, Loo SC, Mornin D. Effect of PAI-1 levels on the molar concentrations of active tissue plasminogen activator (tPA) and tPA/PAI-1 complex in plasma. Blood 1990; 76: 0930-0937
 - 4 Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henney AM. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 1993; 268: 10739-10745